NDC 63302-202

Dermazor Psoriasis and Seborrheic Dermatitis

Salicylic Acid, Zinc Oxide

Dermazor Psoriasis and Seborrheic Dermatitis is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Prestigio Ltd. The primary component is Salicylic Acid.

• Product ID: 63302-202_021795fb-d31e-446b-838a-67461a32221c
• NDC: 63302-202
• Product Type: Human Otc Drug
• Proprietary Name: Dermazor Psoriasis and Seborrheic Dermatitis
• Generic Name: Salicylic Acid, Zinc Oxide
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2014-05-05
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part333D
• Labeler Name: PRESTIGIO LTD
• Substance Name: SALICYLIC ACID
• Active Ingredient Strength: 3 g/100g
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 63302-202-01

100 g in 1 TUBE (63302-202-01)

• Marketing Start Date: 2014-05-05
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63302-202-01 [63302020201]

Dermazor Psoriasis and Seborrheic Dermatitis CREAM

• Marketing Category: OTC monograph final
• Application Number: part358H
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2014-05-05

NDC 63302-202-02 [63302020202]

Dermazor Psoriasis and Seborrheic Dermatitis CREAM

• Marketing Category: OTC monograph final
• Application Number: part358H
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2017-08-17

Drug Details

Active Ingredients

Ingredient	Strength
SALICYLIC ACID	3 g/100g

OpenFDA Data

• SPL SET ID: df95a616-714e-4727-af91-1b993a55b661
• Manufacturer:
  • PRESTIGIO LTD
• UNII:
  • O414PZ4LPZ
• RxNorm Concept Unique ID - RxCUI:
  • 1537091
  • 416910